GlassScriptPhysician profile
Adam Behroozian
NPI 1962859918
$12,820.24
in general payments reported to CMS, 2019-2025
35 companies · $4,730 in 2025
The $4,730 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $1,557 · 2023: $2,723 · 2024: $3,439 · 2025: $4,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $339 · Travel and Lodging: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,448.39 |
| Education | $339.03 |
| Travel and Lodging | $104.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $3,063.61 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $2,671.56 | 2022-2025 | Mitraclip, Dragonfly Opstar, Aptivue |
| Boston Scientific Corporation | $1,020.57 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Sentinel |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $910.44 | 2021-2024 | Lifevest |
| Medtronic, INC. | $792.52 | 2023-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Abiomed | $788.38 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $447.96 | 2025 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $370.65 | 2022-2025 | Kengreal |
| Novartis Pharmaceuticals Corporation | $351.46 | 2023-2025 | |
| Penumbra, INC. | $301.55 | 2024 | Indigo System |
| Acist Medical Systems, INC. | $265.05 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $206.69 | 2023-2024 | Assure Wcd |
| Cardiac Dimensions, INC. | $148.19 | 2024 | |
| Heartflow, INC. | $146.04 | 2025 | |
| Cook Medical LLC | $137.12 | 2025 | Rosen |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $135.02 | 2022 | |
| Philips North America LLC | $132.22 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Irhythm Technologies, INC. | $117.71 | 2022-2023 | Zio Xt Patch |
| Kiniksa Pharmaceuticals, LTD. | $110.04 | 2022-2023 | Arcalyst |
| W. L. Gore & Associates, INC. | $109.90 | 2025 | Gore Cardioform Septal Occluder |
| Pfizer INC. | $93.15 | 2021-2025 | |
| Teleflex LLC | $60.50 | 2023-2024 | Vascband, Guideliner |
| Getinge USA Sales, LLC | $57.30 | 2023-2024 | Cs300 Intra-Aortic Balloon Pump, English, 110v, Cardiosave Hybrid, Type B Plug |
| Janssen Pharmaceuticals, INC | $55.91 | 2022 | |
| Esperion Therapeutics, INC. | $45.39 | 2023-2024 | Nexletol |
| Recor Medical INC | $42.47 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cardiovascular Systems INC. | $37.74 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $34.77 | 2023-2024 | Farxiga |
| Glaxosmithkline, LLC. | $31.11 | 2023 | Arexvy, Shingrix |
| Lantheus Medical Imaging, INC. | $28.07 | 2024 | |
| Terumo Medical Corporation | $26.22 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $23.16 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $21.84 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.20 | 2022 | |
| Inspire Medical Systems, INC. | $16.73 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Behroozian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.